DR. RHONDA GENTRY MD NPI 1891834016

NPI Details

DR. Rhonda Gentry, MD is a hematology and oncology internal medicine in Little Rock, AR with 23 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Rhonda Gentry, MD NPI is 1891834016. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE
Graduation Year:2002

The provider's business location address is:

8901 CARTI WAY
LITTLE ROCK, AR
ZIP 72205-523
Phone: (501) 906-3000

The NPI 1891834016 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Ferritin (blood protein) level (HCPCS:82728)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Protein measurement, serum (HCPCS:84165)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Magnesium level (HCPCS:83735)
• Nephelometry, test method using light (HCPCS:83883)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Unclassified drugs (HCPCS:J3490)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Automated urinalysis test (HCPCS:81003)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Folic acid level, serum (HCPCS:82746)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Blood test, clotting time (HCPCS:85610)
• Uric acid level, blood (HCPCS:84550)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Vitamin d-3 level (HCPCS:82306)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Blood creatinine level (HCPCS:82565)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Erythropoietin (protein) level (HCPCS:82668)
• Injection of drug or substance into vein (HCPCS:96374)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)

The enumeration date for this NPI number is 2/5/2007 and was last updated on 3/30/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.